Navigation Links
Predicting success

Chemotherapy drugs, given intravenously, are the mainstay of the fight against cancer. But doctors know that sometimes these drugs effect a complete cure, while other times they can be nearly ineffective. How to turn some of those failures into successes? A team of scientists at the Weizmann Institute, headed by Prof. Hadassa Degani of the Biological Regulation Department, has come up with a non-invasive, magnetic resonance imaging- (MRI-) based method for predicting possible problems. The findings of their studies on animals, which appeared in the journal Cancer Research, may, in the future, influence treatment regimes for millions of cancer patients.

Intravenous infusions rely on the bloodstream to carry drugs to where they are needed. Normally, a material such as a chemotherapy drug crosses into a tissue on the principle of concentration equalization ?the material diffuses from an area of high concentration to one of low concentration until the concentrations become equal all around. However, in some cancers, even though the material "wants" to spread out evenly, fluids inside the tumor may be exerting pressure to prevent this. When the internal pressure created by these fluids rises above a certain level, it acts as a barrier that keeps drugs and other materials from entering the tumor.

The method the Institute scientists developed can measure, with a non-invasive MRI scan, whether the fluid pressure in cancer tissues is at levels that could render chemotherapy ineffective. Their research, which led to the method, was done with MRI equipment similar to that found in hospitals and clinics. A contrast agent often employed in MRI was used as a stand-in for chemotherapy drugs, and this material was injected into special mice with different cancerous growths. The team created computer algorithms (instructions for computers) that allowed them to verify the connection between the amount of material that found its way into the growth and the pressure o
'"/>

Source:American Committee for the Weizmann Institute of Science


Page: 1 2

Related biology news :

1. Predicting chemotherapy outcome
2. Predicting successful outcomes in living-donor liver transplants
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Predicting success

(Date:1/22/2015)... , Jan. 13, 2015  Today, FreeWavz ( ... launched its crowdfunding campaign on Fundable, https://www.fundable.com/freewavz ... build of production capacity to meet customer demand. ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a leader ... announced the launch of a TR-FRET (time resolved ... Transcreener UDP Assay, a high throughput screening assay ... assay will allow for sensitive detection of hundreds ...
(Date:1/22/2015)... , Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... commerce market, reports on the recent success of the Wocket™ smart wallet ... Wocket smart wallet was named as one of the "11 Hot ... "5 Best Products Launched At CES So Far" by Newseveryday.com and "The ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... today are genetically modified (GM) to resist insect pests ... one of the most commonly grown GM crops in ... on the long-term health of soils. Although there are ... potentially reducing insecticide use, there may be unintended side ...
... of scientists from the University of Missouri created a ... disease, an inherited neuromuscular disease affecting approximately 150,000 people ... a group of progressive disorders that affects the peripheral ... connects the brain and spinal cord to targets such ...
... /PRNewswire-iReach/ -- Global Information Inc. is pleased ... in the medical devices markets, driven by improving standards ... Renal Dialysis Equipment Market to 2017 The growing ... population are driving rapid growth in the number of ...
Cached Biology News:Genetically modified corn affects its symbiotic relationship with non-target soil organisms 2Genetically modified corn affects its symbiotic relationship with non-target soil organisms 3New genetically engineered mice aid understanding of incurable neuromuscular disease 2Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows 2Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows 3Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows 4
(Date:2/27/2015)... A paper published today, " Financing ... in Science Translational Medicine, demonstrates the ... the risk associated with investing in the treatment ... of funding for developing so-called "orphan" drugs. ... between scientists at the National Center for Advancing ...
(Date:2/27/2015)... 27, 2015 The fully automated ... UC) can sequentially analyze up to 48 samples ... high-sensitivity detection of targets by mass spectrometry. ... fulfill the measurement requirements of a wide range ... drug delivery and search for disease biomarkers, additives ...
(Date:2/27/2015)... February 27, 2015 FamilyFarms Group is ... Manager of State Line Farms, received the 2015 Tomorrow’s ... producer, under the age of 35, who has demonstrated ... an honor to win the Tomorrow's Top Producer Horizon ... won the Top Producer Award and learning from their ...
(Date:2/27/2015)... BOSTON , Feb. 27, 2015   PureTech ... identifying, inventing and commercializing disruptive products and technologies in ... Christopher Viehbacher , former CEO and Member of the ... Directors.  "It,s has been a pleasure ... very excited that we will be working together more ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4
... Convergence, the architecture for voice, video and integrated data ... word virtual. It is no longer a murky technology ... eliminating boarders, physical boundaries, brick and mortar, convergence allows ... cost, thus increasing productivity as well as the bottom ...
... take advantage of the limitless minutes now included in ... a device that can significantly improve the quality of ... ,"When you've been talking on a cell phone for ... gets," notes Zhenqiang "Jack" Ma, an assistant professor of ...
... MADISON - Ohio State University's new "living laboratory" ... media-presentation system developed by Madison-based Sonic Foundry, ... view instructors' presentations, the company announced Monday. , ... to provide Ohio State with data for making ...
Cached Biology Technology:WTN Visions: Convergence is changing business 2WTN Visions: Convergence is changing business 3UW-Madison technology to advance cell phones 2UW-Madison technology to advance cell phones 3Ohio State's educational tech lab to use Sonic Foundry system 2
Human FGF R2 (alpha isoforms) MAb (Clone 98706)...
dithiothreitol, sulfhydryl reducing agent, C4H10O2S2; MW: 154.24, 97% pure (minimum), CAS No: 27565-41-9, store at -20 C ...
... Nucleon HT, 1 kit. Facilitates the simple, ... sections and hard tissue requiring proteinase K ... quality DNA from 50 preparations of up ... DNA/RNA Synthesis & Purification, Purification and Amplification ...
Human LT beta R/TNFRSF3 Phycoerythrin MAb (Clone 71319)...
Biology Products: